A LinkedIn post from Cato Networks emphasizes the compliance and liability implications for organizations using third-party vendors in healthcare-related contexts. The post argues that without both SOC 2 Type II and HIPAA attestation, customers may retain significant regulatory exposure and face greater audit friction when relying on external providers.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, SOC 2 Type II is positioned as evidence that a vendor’s controls operate effectively over time, while HIPAA attestation is framed as alignment with healthcare-specific safeguards. The messaging suggests that healthcare and health-adjacent enterprises may increasingly favor vendors that combine security certifications with sector-specific compliance assurances.
For investors, this focus on dual compliance could indicate Cato Networks is targeting regulated verticals such as healthcare, where risk mitigation and audit readiness are high-value differentiators. If the company can successfully convert this compliance posture into contracts with large healthcare systems and insurers, it may support higher recurring revenue, improved customer stickiness, and a stronger competitive position in security and networking markets.
The post also directs readers to a blog on “trust you can audit,” implying an effort to build a brand around verifiable, audit-friendly controls rather than purely marketing claims. This approach may appeal to risk-averse enterprise buyers and procurement teams, which could lengthen sales cycles but potentially increase deal sizes and multi-year commitments, with implications for revenue visibility and valuation multiples.